Renal Dysfunction and Outcomes in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention von Abughofah, Yousaf, Anderson, Wesley L., Kreutz, Rolf P.

Volltext

Sex specific differences of factor XI and relationship with other coagulation factors von Kreutz, Rolf P., Ipe, Joseph, Skaar, Todd C.

Volltext

Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants von Kanuri, Sri H, Kreutz, Rolf P

Volltext

IL-1R (Interleukin-1 Receptor) Signaling and Attenuated Hepatic CYP (Cytochrome P450) 2C Expression: Explanation for Higher Rate of Clopidogrel Resistance in Patients With Diabetes... von Kreutz, Rolf P.

Volltext

Clopidogrel Pharmacogenomics: Validation in a Population of South-Asian Ancestry von Kreutz, Rolf P

Volltext

Intensified P2Y12 inhibition for high-on treatment platelet reactivity von Mshelbwala, Fakilahyel S., Hugenberg, Daniel W., Kreutz, Rolf P.

Volltext

Isolated Right Ventricular Myocardial Infarction Presenting With Anterior ST-Segment Elevation von Mallory, Ryan, Kreutz, Rolf P

Volltext

Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson von Bitar, Abbas, Mastouri, Ronald, Kreutz, Rolf P

Volltext

Plasma and Whole Blood Clot Strength Measured by Thrombelastography in Patients Treated with Clopidogrel during Acute Coronary Syndromes von Lu, Deshun, Owens, Janelle, Kreutz, Rolf P

Volltext

Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography von Maatman, Benjamin T., Kreutz, Rolf P., Schmeisser, Glen

Volltext

Variations in Clinical Presentation, Risk Factors, Treatment, and Prognosis of Spontaneous Coronary Artery Dissection von Sultan, Adnan, Kreutz, Rolf P

Volltext

Platelet Activation and Pneumonia von Gurbel, Paul A., MD, Kreutz, Rolf P., MD, Bliden, Kevin P., MBA, Tantry, Udaya S., PhD

Volltext

Amlodipine – not a significant contributor to clopidogrel non-response? von Kreutz, Rolf P, Flockhart, David A

Volltext

A comprehensive review and meta-analysis of risk factors for statin-induced myopathy von Nguyen, Khoa A., Li, Lang, Lu, Deshun, Yazdanparast, Aida, Wang, Lei, Kreutz, Rolf P., Whipple, Elizabeth C., Schleyer, Titus K.

Volltext

Role of Thrombelastography (TEG) in Risk Assessment and Guidance of Antithrombotic Therapy in Patients with Coronary Artery Disease von Bitar, Abbas, Kreutz, Rolf P.

Volltext

Spontaneous coronary artery dissection in a 14-year-old von Cropp, Elliott M., MD, Turner, Joseph S., MD, Kreutz, Rolf P., MD

Volltext

CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings von Beitelshees, Amber L, Thomas, Cameron D, Empey, Philip E, Stouffer, George A, Angiolillo, Dominick J, Franchi, Francesco, Tuteja, Sony, Limdi, Nita A, Lee, James C, Duarte, Julio D, Kreutz, Rolf P, Skaar, Todd C, Coons, James C, Giri, Jay, McDonough, Caitrin W, Rowland, Rachel, Stevenson, James M, Thai, Thuy, Vesely, Mark R, Wellen, Jacob T, Johnson, Julie A, Winterstein, Almut G, Cavallari, Larisa H, Lee, Craig R

Volltext

Platelet Activation and Pneumonia: Is Soluble P-Selectin the Right Marker? von Gurbel, Paul A., Kreutz, Rolf P., Bliden, Kevin P., Tantry, Udaya S.

Volltext

MicroRNA sequencing in patients with coronary artery disease – considerations for use as biomarker for thrombotic risk von Onuoha, Chimnonso P., Ipe, Joseph, Simpson, Edward, Liu, Yunlong, Skaar, Todd C., Kreutz, Rolf P.

Volltext

Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study von Kreutz, Rolf P., Stanek, Eric J., Aubert, Ronald, Yao, Jianying, Breall, Jeffrey A., Desta, Zeruesenay, Skaar, Todd C., Teagarden, J. Russell, Frueh, Felix W., Epstein, Robert S., Flockhart, David A.

Volltext